Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc

is 20.71%. Trinity Biotech's ROA for the same period is 5.89%. The trailing-twelve-month profit margin at Meridian Bioscience

is 19.23%. Meridian Bioscience's revenue for the same period is $173.54 million. The trailing-twelve-month profit margin at IDEXX Laboratories

is 13.50%. IDEXX Laboratories' PEG ratio is 1.91. The trailing-twelve-month profit margin at Neogen

is 12.35%. Neogen's ROE for the same period is 10.90%.